IMM 18.6% 35.0¢ immutep limited

Hello DigsterSouthoz said"Mainly because it seemed clear that...

  1. 1,234 Posts.
    lightbulb Created with Sketch. 97
    Hello Digster

    Southoz said
    "Mainly because it seemed clear that there would not be an update for Overall Survival (OS) from Can-003 until the end of the year. "

    I have not been able to listen to the presentation you both reference and was wondering if you got the same impression regarding no OS update for CAN-003 is to be presented by Dr Gray at the ASCO meeting the end of next month.

    This seems to contradict the news from the company that they posted 28/3/2014
    "Dr. Gray will present the final progression-free survival data (PFS) and an update on overall survival (OS) from the Randomized, Open-Label Phase IIb Trial of Maintenance Therapy with a MUC1 Dendritic Cell Vaccine (CVacTM) for Epithelial Ovarian Cancer Patients in First or Second Remission (Prima protocol CAN-003)."
    Thanks in advance.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
0.055(18.6%)
Mkt cap ! $504.7M
Open High Low Value Volume
36.0¢ 37.5¢ 33.5¢ $5.658M 15.86M

Buyers (Bids)

No. Vol. Price($)
24 404059 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 143764 4
View Market Depth
Last trade - 15.11pm 12/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.